London,:October 9,2008 - IR Summary/Agencies - The drug recently reported to be a sure cure by Researchers at Southampton University for testicular cancer has created stir amaong youth. The affected youth have taken it a good news for them  that just a single dose of chemotherapy drug may help the testicular cancer,  a common form of testicular cancer.

The drug has just a minor side effects, but these are not serious. The patient can resume his normal duties within a reasonable period, quite soon.

The Researchers have found that the injection can effectively cure early stage seminoma with fewer side effects than radiotherapy.

The vast majority of cases include "seminomas", affecting the sperm-producing cells in the testicle, and almost half of these are caught at an early stage.

Men, with this form of cancer often have their affected testicle removed, and are then offered either a single dose of carboplatin chemotherapy, a longer regime of radiotherapy, or the option to have no extra treatment with a higher risk of the cancer returning.

Study leader Dr Ben Mead has revealed that the research team looked at almost 1,500 patients, 904 given radiotherapy and 573 carboplatin, and found that the rate of relapse in both groups was roughly the same.

The researcher said that the results were "reassuring", and that carboplatin was the better option.

"Giving patients a carboplatin injection rather than radiotherapy is less unpleasant with fewer long-term risks," the BBC quoted Mead as saying.
"